mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.6 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.8 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.06 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.02 |